Literature DB >> 21783402

Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas.

Sonja C Boy1, Marlene B van Heerden, Chantal Babb, Willie F van Heerden, Pascale Willem.   

Abstract

We present common cytogenetic features in the largest cohort of plasmablastic lymphoma (PBL) of the oral cavity published to date. This cohort included 45 patients, 32 of whom had a known HIV status, of which 31 were HIV positive. Ninety eight per cent of all PBL cases were known to be EBV positive. In line with previous studies, we found that rearrangements of the MYC gene was the most common genetic abnormality seen in 60% of cases with the immunoglobulin heavy chain (IGH) locus as a partner in 51% of cases. Additional complex genetic aberrations were frequent, in particular, an increased copy number of the CCND1 gene was seen in 41% of cases with true amplification of CCND1 in 15% of cases. Aneuploidy was also observed for the BCL6 gene in 28% of cases. Interestingly, rearrangements of both IGH genes were detected in 16% of cases with t(14;18) and t(11;14) respectively involved in conjunction with a t(8;14) in two cases. These bi-allelic IGH rearrangements have not been described before in oral PBL. Our results reinforce the notion that EBV infection and MYC rearrangements are important events in the pathogenesis of oral PBL. The genetic diversity and complexity observed in these cases, underlines the importance to genetically characterise PBL patients at presentation as this may inform the choice of more effective treatment modalities.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21783402     DOI: 10.1016/j.oraloncology.2011.06.506

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  8 in total

1.  Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Hematolymphoid Tumours.

Authors:  Noah A Brown; Kojo S J Elenitoba-Johnson
Journal:  Head Neck Pathol       Date:  2017-02-28

2.  Immune-checkpoint expression in Epstein-Barr virus positive and negative plasmablastic lymphoma: a clinical and pathological study in 82 patients.

Authors:  Camille Laurent; Bettina Fabiani; Catherine Do; Emmanuelle Tchernonog; Guillaume Cartron; Pauline Gravelle; Nadia Amara; Sandrine Malot; Maryknoll Mawanay Palisoc; Christiane Copie-Bergman; Alexandra Traverse Glehen; Marie-Christine Copin; Pierre Brousset; Stefania Pittaluga; Elaine S Jaffe; Paul Coppo
Journal:  Haematologica       Date:  2016-05-12       Impact factor: 9.941

Review 3.  Aggressive B-cell lymphomas: how many categories do we need?

Authors:  Jonathan W Said
Journal:  Mod Pathol       Date:  2012-11-16       Impact factor: 7.842

4.  Genomic characterization of HIV-associated plasmablastic lymphoma identifies pervasive mutations in the JAK-STAT pathway.

Authors:  Laura Pasqualucci; Raul Rabadan; Pascale Willem; Zhaoqi Liu; Ioan Filip; Karen Gomez; Dewaldt Engelbrecht; Shabnum Meer; Pooja N Lalloo; Pareen Patel; Yvonne Perner; Junfei Zhao; Jiguang Wang
Journal:  Blood Cancer Discov       Date:  2020-07

Review 5.  Plasmablastic Lymphoma: A Review of Current Knowledge and Future Directions.

Authors:  Ghaleb Elyamany; Eman Al Mussaed; Ali Matar Alzahrani
Journal:  Adv Hematol       Date:  2015-08-18

Review 6.  Current knowledge on HIV-associated Plasmablastic Lymphoma.

Authors:  Michele Bibas; Jorge J Castillo
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-11-01       Impact factor: 2.576

7.  HIV-related non-Hodgkin lymphomas affecting the oral cavity: a clinicopathologic study of 11 cases.

Authors:  D-C Uchôa; F-S Pontes; L-L Souza; G-S Santos; A-C Prado-Ribeiro; T-B Brandão; L-R Oliveira; C-C Gomes; A-R Santos-Silva; F-P Fonseca; O-P Almeida; H-A Pontes
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-03-01

Review 8.  Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders.

Authors:  Julie Morscio; Thomas Tousseyn
Journal:  World J Transplant       Date:  2016-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.